Teva Pharmaceuticals USA, Inc. has voluntarily recalled 300,133 cartons of Clonidine Transdermal Systems (clonidine), a prescription skin patch used to treat high blood pressure. The recall was initiated because the products were manufactured using unapproved raw materials, which is a violation of current Good Manufacturing Practice (CGMP) standards. No incidents or injuries have been reported to date. These patches were distributed to pharmacies across the United States in various strengths including 0.1 mg/day, 0.2 mg/day, and 0.3 mg/day.
The use of unapproved raw materials during the manufacturing process means the safety and quality of these specific medication lots cannot be guaranteed. This could potentially lead to inconsistent dosing or unexpected side effects for patients using the patches to manage their blood pressure.
You have 2 options:
Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT; Distributed by: Actavis Pharma, Inc
Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT; Distributed by: Actavis Pharma, Inc
Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT; Distributed by: Actavis Pharma, Inc
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.